Samsung Biologics thrives with big deals, eyes ADC for future

Samsung Biologics continues to thrive in the biopharmaceutical industry, attributing its success to speed, quality, and delivery. The company saw an 18 percent increase in revenue in Q3 and raised its revenue forecast for the year.